Coulter Partners Places Industry Veteran Mark Rothera as CEO of TreeFrog Therapeutics
London, UK and Paris, FRANCE – January 27, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search assignment for TreeFrog Therapeutics and is pleased to announce the placement of Mark Rothera as Chief Executive Officer (CEO).